ArticleFrontiers in psychology2022
Final validation of the mental health screening tool for depressive disorders: A brief online and offline screening tool for major depressive disorder.
Article in Frontiers in psychology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed.
- The effectiveness of nature-based therapy for community psychological distress and well-being during COVID-19: a multi-site trial.Scientific reports · 2023Trial
- Occupational Stress in the Neuroticism-Burnout Link: An Exploratory Examination of Physiological Contributions.Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology · 2026Article
- The Applicability of Forest Therapy for Socially Isolated Young Adults: Parallel Changes in Psychological Distress and Mindfulness.International journal of environmental research and public health · 2026Article
- Development and Initial Validation of a Brief, Online Version of the Center for Epidemiological Studies Depression Scale (CES-D): Psychometric Study.JMIR formative research · 2026Article
- MOODMIND: A Pilot Feasibility Study of Artificial Intelligence for Major Depressive Disorder Screening in Tuberculosis Patients.F1000Research · 2025Article
- The feasibility of a two-day intensive forest therapy incorporating mindfulness practices for natural disaster-affected individuals: a brief report.Frontiers in psychology · 2025Article
- The concept of the digital therapeutic garden and its psychological effects.Frontiers in psychology · 2025Article
- Longitudinal relationships between daily activities, depressive symptoms, anxiety, and suicidality during the COVID-19 pandemic: a three-wave cross-lagged study.Frontiers in public health · 2025Article
- Screening mental health risks for adolescents in South Korea.Frontiers in psychology · 2025Article
- Differential benefits of internet-based behavioral activation (iBA) for adolescents with high vs. low reward probability: a secondary analysis.Frontiers in psychology · 2025Article
- Validation of the Japanese version of the Patient Health Questionnaire-4 (PHQ-4-J) to screen for depression and anxiety.Discover mental health · 2024Article
- Clinical Implication of Maumgyeol Basic Biotypes-Electroencephalography- and Photoplethysmogram-Based Bwave State Inventory.Psychiatry investigation · 2024Article
- Cognitive Screening and Hearing Assessment in Patients With Chronic Tinnitus.Clinical and experimental otorhinolaryngology · 2024Article
- Effectiveness of social and therapeutic horticulture for reducing symptoms of depression and anxiety: a systematic review and meta-analysis.Frontiers in psychiatry · 2024Review
- Development and validation of the core life activities scale.Frontiers in psychology · 2024Article
- Clinical Implication of Maumgyeol Basic Service-the 2 Channel Electroencephalography and a Photoplethysmogram-based Mental Health Evaluation Software.Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology · 2023Article
- Social distancing policy and mental health during COVID-19 pandemic: an 18-month longitudinal cohort study in South Korea.Frontiers in psychology · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Early screening for depressive disorders is crucial given that major depressive disorder (MDD) is one of the main reasons of global burden of disease, and depression is the underlying cause for 60% of suicides. The need for an accurate screening for depression with high diagnostic sensitivity and specificity in a brief and culturally adapted manner has emerged. This study reports the final stage of a 3-year research project for the development of depression screening tool. The developed Mental Health Screening Tool for Depressive Disorders (MHS:D) was designed to be administered in both online and offline environments with a high level of sensitivity and specificity in screening for major depressive disorder. A total of 527 individuals completed two versions (online/offline) of the MHS:D and existing depression scales, including the BDI-II, CES-D, and PHQ-9. The Mini International Neuropsychiatric Interview (MINI) for diagnostic sensitivity/specificity was also administered to all participants. Internal consistency, convergent validity, factor analysis, item response theory analysis, and receiver operating characteristics curve (ROC) analysis were performed. The MHS:D showed an excellent level of internal consistency and convergent validity as well as a one-factor model with a reasonable level of model fit. The MHS:D could screen for major depressive disorder accurately (0.911 sensitivity and 0.878 specificity for both online and paper-pencil versions). Item response theory analysis suggested that items from the MHS:D could provide significantly more information than other existing depression scales. These statistical analyses indicated that the MHS:D is a valid and reliable scale for screening Korean patients with MDD with high diagnostic sensitivity and specificity. Moreover, given that the MHS:D is a considerably brief scale that can be administered in either online or paper-pencil versions, it can be used effectively in various contexts, particularly during the pandemic.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.